These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8909030)

  • 1. Effect of media on growth rate and susceptibility testing of Cryptococcus neoformans.
    St-Germain G; Dion C
    Mycoses; 1996; 39(5-6):201-6. PubMed ID: 8909030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility testing of Cryptococcus neoformans: a microdilution technique.
    Ghannoum MA; Ibrahim AS; Fu Y; Shafiq MC; Edwards JE; Criddle RS
    J Clin Microbiol; 1992 Nov; 30(11):2881-6. PubMed ID: 1452658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Cryptococcus neoformans by the NCCLS microdilution and Etest methods using five defined media.
    Petrou MA; Shanson DC
    J Antimicrob Chemother; 2000 Nov; 46(5):815-8. PubMed ID: 11062205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
    Aller AI; Martín-Mazuelos E; Gutiérrez MJ; Bernal S; Chávez M; Recio FJ
    J Antimicrob Chemother; 2000 Dec; 46(6):997-1000. PubMed ID: 11102421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
    Del Poeta M; Barchiesi F; Morbiducci V; Arzeni D; Marinucci G; Ancarani F; Scalise G
    J Chemother; 1994 Jun; 6(3):173-6. PubMed ID: 7983499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients.
    Jessup CJ; Pfaller MA; Messer SA; Zhang J; Tumberland M; Mbidde EK; Ghannoum MA
    J Clin Microbiol; 1998 Oct; 36(10):2874-6. PubMed ID: 9738036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome?
    Viviani MA; Esposto MC; Cogliati M; Tortorano AM
    J Chemother; 2003 Apr; 15(2):124-8. PubMed ID: 12797387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of broth macrodilution, broth microdilution and E-test susceptibility tests of Cryptococcus neoformans for fluconazole.
    Chryssanthou E; Grönfors C; Khanna N
    Mycoses; 1997 Dec; 40(11-12):423-7. PubMed ID: 9470407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia city, Goiás, Brazil.
    Souza LK; Fernandes Ode F; Kobayashi CC; Passos XS; Costa CR; Lemos JA; Souza-Júnior AH; Silva Mdo R
    Rev Inst Med Trop Sao Paulo; 2005; 47(5):253-6. PubMed ID: 16302107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
    Espinel-Ingroff A; Canton E; Gibbs D; Wang A
    J Clin Microbiol; 2007 Mar; 45(3):858-64. PubMed ID: 17215342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole.
    Davey KG; Johnson EM; Holmes AD; Szekely A; Warnock DW
    J Antimicrob Chemother; 1998 Aug; 42(2):217-20. PubMed ID: 9738839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.
    Abdel-Salam HA
    Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose.
    Rodríguez-Tudela JL; Martín-Díez F; Cuenca-Estrella M; Rodero L; Carpintero Y; Gorgojo B
    Antimicrob Agents Chemother; 2000 Feb; 44(2):400-4. PubMed ID: 10639369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine.
    Boon-Long J; Mekha N; Poonwan N; Kusum M; Mikami Y; Yazawa K; Konyama K
    Mycoses; 1996; 39(11-12):453-6. PubMed ID: 9145003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.
    Dannaoui E; Abdul M; Arpin M; Michel-Nguyen A; Piens MA; Favel A; Lortholary O; Dromer F;
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2464-70. PubMed ID: 16801427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
    Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.
    Rodríguez-Tudela JL; Berenguer J; Martínez-Suárez JV; Sanchez R
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1998-2003. PubMed ID: 8878570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media.
    Anaissie E; Shawar R; Paetznick V; Ensign LG; Witte Z; LaRocco M
    J Clin Microbiol; 1993 May; 31(5):1370-2. PubMed ID: 8501245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.